Preoperative 6-minute walk distance accurately predicts postoperative complications after operations for hepato-pancreato-biliary cancer

详细信息    查看全文

• 作者：Kazuhiro Hayashi ; PT ; MSc^a ; ^{hayashi.k@med.nagoya-u.ac.jp} ; Yukihiro Yokoyama ; MD ; PhD^b ; Hiroki Nakajima ; PT^a ; Masato Nagino ; MD ; PhD^b ; Takayuki Inoue ; PT ; PhD^a ; Motoki Nagaya ; PT ; MSc^a ; Keiko Hattori ; PT^a ; Izumi Kadono ; MD ; MSc^a ; ^c ; Satoru Ito ; MD ; PhD^a ; ^d ; Yoshihiro Nishida ; MD ; PhD^a ; ^c
• 刊名：Surgery
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：161
• 期：2
• 页码：525-532
• 全文大小：263 K
• 卷排序：161

文摘

Operation for hepato-pancreato-biliary cancer is among the most invasive open abdominal operations, with a high postoperative morbidity and mortality rate. The purpose of the present study is to investigate whether a preoperative 6-minute walk distance can predict major postoperative complications after operation for hepato-pancreato-biliary diseases.MethodsA total of 81 participants who underwent pancreaticoduodenectomy, major hepatectomy with extrahepatic bile duct resection, or hepatopancreatoduodenectomy were included. The 6-minute walk distance was performed within 1 week before operation. Patients were categorized into 2 groups based on surgical complications: Clavien-Dindo grade <3 and Clavien-Dindo grade ≥3. Clinical differences between the 2 groups were analyzed. Multivariate logistic regression analysis was performed to identify risk factors for postoperative complications that were categorized as Clavien-Dindo grade ≥3.ResultsThe multiple logistic regression model revealed a significant correlation between major postoperative complications and preoperative low 6-minute walk distance, low body mass index, and major blood loss. In patients with 6-minute walk distance <400 m (1,312 feet), the Clavien-Dindo grade was considerably greater than patients with ≥400 m.ConclusionThe 6-minute walk distance is useful in identifying patients with a greater chance of developing major postoperative complications after surgery for hepato-pancreato-biliary cancer.